Proposal of a new staging system for intrahepatic cholangiocarcinoma: Analysis of surgical patients from a nationwide survey of the Liver Cancer Study Group of Japan

Cancer

Volumn 122, Issue 1, 2016, Pages 61-70

  Sakamoto, Yoshihiro ^a   Kokudo, Norihiro ^a   Matsuyama, Yutaka ^b   Sakamoto, Michiie ^c   Izumi, Namiki ^d   Kadoya, Masumi ^e   Kaneko, Shuichi ^f   Ku, Yonson ^g   Kudo, Masatoshi ^h   Takayama, Tadatoshi ⁱ   Nakashima, Osamu ^j  

^a UNIVERSITY OF TOKYO HOSPITAL   (Japan)

^b UNIVERSITY OF TOKYO   (Japan)

^c KEIO UNIVERSITY   (Japan)

^d MUSASHINO RED CROSS HOSPITAL   (Japan)

^e SHINSHU UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^f KANAZAWA UNIVERSITY HOSPITAL   (Japan)

^g KOBE UNIVERSITY   (Japan)

^h KINKI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

ⁱ NIHON UNIVERSITY   (Japan)

^j KURUME UNIVERSITY HOSPITAL   (Japan)

more..

Author keywords

biliary invasion; intrahepatic cholangiocarcinoma; periductal invasion; staging system; tumor size

Indexed keywords

ARTICLE; BILE DUCT CARCINOMA; CANCER PROGNOSIS; CANCER STAGING; CANCER SURGERY; CANCER SURVIVAL; CONTROLLED STUDY; HUMAN; JAPAN; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; OVERALL SURVIVAL; PRIORITY JOURNAL; SURVIVAL RATE; SURVIVAL TIME; TUMOR CLASSIFICATION; TUMOR INVASION; TUMOR VOLUME; BILE DUCT NEOPLASMS; CHOLANGIOCARCINOMA; CLINICAL TRIAL; COHORT ANALYSIS; MULTICENTER STUDY; MULTIVARIATE ANALYSIS; PATHOLOGY; PROCEDURES; PROGNOSIS; QUESTIONNAIRE;

BILE DUCT NEOPLASMS; CHOLANGIOCARCINOMA; COHORT STUDIES; HUMANS; JAPAN; MULTIVARIATE ANALYSIS; NEOPLASM STAGING; PROGNOSIS; SURVEYS AND QUESTIONNAIRES; SURVIVAL RATE;

EID: 84945162176     PISSN: 0008543X     EISSN: 10970142     Source Type: Journal    
DOI: 10.1002/cncr.29686     Document Type: Article

References (20)

1. Nakanuma Y, Curado MP, Fanceschi S, et al., Intrahepatic cholangiocarcinoma. In:, Bosman FT, Carnerio F, Hruban RH, Theise ND, eds. WHO Classification of Tumours of the Digestive System. 4th ed. Lyon, France: International Agency for Research on Cancer; 2010: 217-214.
2. Khan SA, Toledano MB, Taylor-Robinson SD,. Epidemiology, risk factors, and pathogenesis of cholangiocarcinoma. HPB (Oxford). 2008; 10: 77-82.
3. Shaib YH, Davila JA, McGlynn K, et al., Rising incidence of intrahepatic cholangiocarcinoma in the United States: a true increase? J Hepatol. 2004; 40: 472-477.
4. Shaib YH, EL-Serag HB, Daliva JA, et al., Risk factors of intrahepatic cholangiocarcinoma in the United States: a case-control study. Gastroenterology. 2005; 128: 620-626.
5. Nathan H, Aloia TA, Vauthey JN, et al., A proposed staging system for intrahepatic cholangiocarcinoma. Ann Surg Oncol. 2009; 16: 14-22.
6. de Jong MC, Nathan H, Sotiropoulos GC, et al., Intrahepatic cholangiocarcinoma: an international multi-institutional analysis of prognostic factors and lymph node assessment. J Clin Oncol. 2011; 29: 3140-3145.
7. Uchiyama K, Yamamoto M, Yamaue H, et al., Impact of nodal involvement on surgical outcomes of intrahepatic cholangiocarcinoma: a multicenter analysis by the Study Group for Hepatic Surgery of the Japanese Society of Hepato-Biliary-Pancreatic Surgery. J Hepatobiliary Pancreat Sci. 2011; 18: 443-452.
8. Valle J, Wasan H, Palmer DH, et al,; ABC-02 Trial Investigators. Cisplatin plus gemcitabine versus gemcitabine for biliary tract cancer. N Engl J Med. 2010; 362: 1273-1281.
9. Liver Cancer Study Group of Japan. General Rules for the Clinical and Pathological Study of Primary Liver Cancer. First English edition. Tokyo, Japan: Kanehara & Co Ltd; 1997.
10. Okabayashi T, Yamamoto J, Kosuge T, et al., A new staging system for mass-forming intrahepatic cholangiocarcinoma: analysis of preoperative and postoperative variables. Cancer. 2001; 92: 2374-2383.
11. Edge S, Byrd DR, Compton CC, Fritz AG, Greene FL, Trotti A, eds. AJCC Cancer Staging Manual. 7th ed. New York, NY: Springer; 2010.
12. Farges O, Fuks D, Le Treut YP, et al., AJCC 7th edition of TNM staging accurately discriminates outcomes of patients with resectable intrahepatic cholangiocarcinoma. Cancer. 2011; 117: 2170-2177.
13. Bridgewater J, Galle PR, Khan SA, et al., Guidelines for the diagnosis and management of intrahepatic cholangiocarcinoma. J Hepatol. 2014; 60: 1268-1289.
14. Yamasaki S,. Intrahepatic cholangiocarcinoma: macroscopic type and stage classification. J Hepatobiliary Pancreat Surg. 2003; 10: 288-291.
15. Yamamoto M, Takasaki K, Yoshikawa T, Ueno K, Nakano M,. Does gross appearance indicate prognosis in intrahepatic cholangiocarcinoma? J Surg Oncol. 1998; 69: 162-167.
16. Wang Y, Li J, Xia Y, et al., Prognostic nomogram for intrahepatic cholangiocarcinoma after partial hepatectomy. J Clin Oncol. 2013; 31: 1188-1195.
17. Inoue K, Makuuchi M, Takayama T, et al., Long-term survival and prognostic factors in the surgical treatment of mass-forming type cholangiocarcinoma. Surgery. 2000; 127: 498-505.
18. Shimada K, Sano T, Nara S, et al., Therapeutic value of lymph node dissection during hepatectomy in patients with intrahepatic cholangiocellular carcinoma with negative lymph node involvement. Surgery. 2009; 145: 411-416.
19. Uenishi T, Ariizumi S, Aoki T, et al., Proposal of a new staging system for mass-forming intrahepatic cholangiocarcinoma: a multicenter analysis by the Study Group for Hepatic Surgery of the Japanese Society of Hepato-Biliary-Pancreatic Surgery. J Hepatobiliary Pancreat Sci. 2014; 21: 499-508.
20. Yamamoto Y, Shimada K, Sakamoto Y, et al., Clinicopathological characteristics of intrahepatic cholangiocellular carcinoma presenting intrahepatic bile duct growth. J Surg Oncol. 2009; 99: 161-165.